Abstract:Background: Precise gene dosage of the X chromosomes is critical for normal development and cellular function. In mice, XX female somatic cells show transcriptional X chromosome upregulation of their single active X chromosome, while the other X chromosome is inactive. Moreover, the inactive X chromosome is reactivated during development in the inner cell mass and in germ cells through X chromosome reactivation, which can be studied in vitro by reprogramming of somatic cells to pluripotency. How chromatin processes and gene regulatory networks evolved to regulate X chromosome dosage in the somatic state and during X chromosome reactivation remains unclear. Results: Using genome-wide approaches, allele-specific ATAC-seq and single-cell RNA-seq, in female embryonic fibroblasts and during reprogramming to pluripotency, we show that chromatin accessibility on the upregulated mammalian active X chromosome is increased compared to autosomes. We further show that increased accessibility on the active X chromosome is erased by reprogramming, accompanied by erasure of transcriptional X chromosome upregulation and the loss of increased transcriptional burst frequency. In addition, we characterize gene regulatory networks during reprogramming and X chromosome reactivation, revealing changes in regulatory states. Our data show that ZFP42/REX1, a pluripotency-associated gene that evolved specifically in placental mammals, targets multiple X-linked genes, suggesting an evolutionary link between ZFP42/REX1, X chromosome reactivation, and pluripotency. Conclusions: Our data reveal the existence of intrinsic compensatory mechanisms that involve modulation of chromatin accessibility to counteract X-to-Autosome gene dosage imbalances caused by evolutionary or in vitro X chromosome loss and X chromosome inactivation in mammalian cells.

Distinct Dosage Compensations of Ploidy-Sensitive and -Insensitive X Chromosome Genes During Development and in Diseases.

Comprehensively Characterizing Evolutionarily Conserved Differential Dosage Compensations of the X Chromosome During Development and in Diseases

Identifying New Regulators of Evolutionarily Conserved Differential Chromosome X Dosage Compensation

Dynamic Spatial-Temporal Expression Ratio of X Chromosome to Autosomes but Stable Dosage Compensation in Mammals

Elastic dosage compensation by X-chromosome upregulation

Enhanced chromatin accessibility contributes to X chromosome dosage compensation in mammals

Dosage Compensation in the Process of Inactivation/reactivation During Both Germ Cell Development and Early Embryogenesis in Mouse.

Non-Canonical and Sexually Dimorphic X Dosage Compensation States in the Mouse and Human Germline

Chromosome X Dosage Modulates Development of Aneuploidy in Genetically Diverse Mouse Embryonic Stem Cells

Dosage Sensitivity of X-linked Genes in Human Embryonic Single Cells

Pseudoautosomal Region 1 Overdosage Affects the Global Transcriptome in iPSCs From Patients With Klinefelter Syndrome and High-Grade X Chromosome Aneuploidies

Dosage Compensation Mechanism of X Chromosome

A critical role for X-chromosome architecture in mammalian X-chromosome dosage compensation

Stable and robust Xi and Y transcriptomes drive cell-type-specific autosomal and Xa responses in vivo and in vitro in four human cell types

Stable and robust Xi and Y transcriptomes drive cell-type-specific autosomal and Xa responses and in four human cell types

A Small Proportion of X-linked Genes Contribute to X Chromosome Upregulation in Early Embryos Via BRD4-mediated Transcriptional Activation

Imprinted X Chromosome Inactivation at the Gamete-to-embryo Transition

The Evolution of Sex Chromosome Dosage Compensation in Animals.

Human X chromosome inactivation and gene dosage compensation effect

Post-transcriptional cross- and auto-regulation buffer expression of the human RNA helicases DDX3X and DDX3Y